# AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis

Study · id `cardio:ct-nct05649904` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05649904](<https://clinicaltrials.gov/study/NCT05649904>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05649904

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

## Technical summary

Registry record NCT05649904. Randomized; no masking; primary purpose treatment. Start 2023-02-07 (actual); primary completion 2026-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 240 participants (planned count; ClinicalTrials.gov record NCT05649904, source copy `cardio:ctgov-nct05649904-2025-04-01`, retrieved 2026-10-31)
- Started: 2023-02-07 (actual) (ClinicalTrials.gov record NCT05649904, source copy `cardio:ctgov-nct05649904-2025-04-01`, retrieved 2026-10-31)
- Primary completion: 2026-01 (anticipated) (ClinicalTrials.gov record NCT05649904, source copy `cardio:ctgov-nct05649904-2025-04-01`, retrieved 2026-10-31)
- Completion: 2026-01 (anticipated) (ClinicalTrials.gov record NCT05649904, source copy `cardio:ctgov-nct05649904-2025-04-01`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT05649904, source copy `cardio:ctgov-nct05649904-2025-04-01`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05649904-2025-04-01`, retrieved 2026-10-31)

## The registry's words

- Brief title: AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
- Acronym: AFFECT
- Condition: Intraventricular Hemorrhage
- Condition: Subarachnoid Hemorrhage
- Condition: Subdural Hematoma
- Condition: Ventriculitis
- Intervention (Device): IRRAflow with Active Fluid Exchange System
- Intervention (Device): External Ventricular Drain
- Lead sponsor: Ohio State University
- Lead sponsor class: OTHER
- Collaborator: IRRAS
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as the lead sponsor: Ohio State University (`cardio:org-ohio-state-university`)

## Provenance

Content hash: 35a7bca688e8b97e3d0c36271e643095b62c2a4a70e26168d0ad5a336e8d6fbc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
